Clinical Trial Research
Research from University of Birmingham in the area of clinical trial research described
Published in Medicine and Law Weekly, June 22nd, 2007
A new study, "Quantifying emerging drugs for very rare conditions," is now available. "EU legislation is encouraging pharmaceutical companies to develop drugs for rare conditions, but their often high cost, and potential for long-term administration has led to debate about their affordability and cost-effectiveness. To investigate how many drugs are in development for very rare conditions," researchers in Birmingham, the United Kingdom report.
"We defined very rare conditions as having a prevalence of <1:50,000, and identified pharmaceuticals in phase II, phase III trials or pre-registration for these conditions using commercial databases. We identified 42 very rare...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
More Articles from Medicine and Law Weekly
- Alcoholism Therapy
Study findings from Johns Hopkins University provide new insights into alcoholism therapy - Epidemiology
Researchers at Mayo Clinic, Division of General Internal Medicine target epidemiology - Health Policy
New health policy study results from Taipei Medical University described - Health Policy
New health policy study results reported from University of Toronto, Joint Center for Bioethics - Health Policy
Research from Institute of Public Health Research, Research Department reveals new findings on health policy - Health Policy
Research from McMaster University, Center for Health Economics and Policy Analysis provides new data about health policy - More from this issue of Medicine and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
